{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:20:14Z","timestamp":1787872814421,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005224","name":"National Center for Immunization and Respiratory Diseases","doi-asserted-by":"publisher","award":["75D30118F02850"],"award-info":[{"award-number":["75D30118F02850"]}],"id":[{"id":"10.13039\/100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL151498"],"award-info":[{"award-number":["HL151498"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008769","name":"Abt Global","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127361","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:48:11Z","timestamp":1750286891000},"page":"127361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel"],"prefix":"10.1016","volume":"61","author":[{"given":"Margarita","family":"Mishina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean D.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Shanmugasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin D.","family":"Bohannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Z.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Jorge","family":"Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Dobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavan","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah S.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjusha","family":"Gaglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprakash","family":"Gangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.vaccine.2025.127361_bb0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127361_bb0010","author":"CDC"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127361_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1334554","article-title":"Repeated annual influenza vaccination and vaccine effectiveness: review of evidence","volume":"16","author":"Belongia","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127361_bb0020","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jix074","article-title":"Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during a(H3N2) epidemics in Canada, 2010-2011 to 2014-2015","volume":"215","author":"Skowronski","year":"2017","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127361_bb0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1001\/jama.281.10.908","article-title":"Effectiveness of influenza vaccine in health care professionals: a randomized trial","volume":"281","author":"Wilde","year":"1999","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127361_bb0030","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/infdis\/jit825","article-title":"Antibody response to influenza a(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine","volume":"209","author":"Gaglani","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127361_bb0035","first-page":"ofu115","article-title":"Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open forum","volume":"2","author":"Laguio-Vila","year":"2015","journal-title":"Infect Dis Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127361_bb0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.vaccine.2015.10.119","article-title":"Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to a\/Perth\/16\/2009 (H3N2)-like virus during 2010-11","volume":"34","author":"Thompson","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127361_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00838-21","article-title":"An egg-derived Sulfated N-Acetyllactosamine glycan is an antigenic decoy of influenza virus vaccines","volume":"12","author":"Guthmiller","year":"2021","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127361_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146138","article-title":"Age-specific effects of vaccine egg adaptation and immune priming on a(H3N2) antibody responses following influenza vaccination","volume":"131","author":"Liu","year":"2021","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127361_bb0055","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/nm.4223","article-title":"Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain","volume":"22","author":"Raymond","year":"2016","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127361_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127361_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006682","article-title":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLoS Pathog"},{"issue":"47","key":"10.1016\/j.vaccine.2025.127361_bb0070","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127361_bb0075","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40265-019-01176-z","article-title":"Cell-based quadrivalent inactivated influenza virus vaccine (Flucelvax((R)) tetra\/Flucelvax quadrivalent((R))): a review in the prevention of influenza","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127361_bb0080","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1016\/j.vaccine.2020.06.023","article-title":"A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children","volume":"38","author":"Moehling","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127361_bb0085","doi-asserted-by":"crossref","first-page":"e4312","DOI":"10.1093\/cid\/ciaa1352","article-title":"Comparison of a(H3N2) neutralizing antibody responses elicited by 2018-2019 season quadrivalent influenza vaccines derived from eggs, cells, and recombinant hemagglutinin","volume":"73","author":"Wang","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127361_bb0090","doi-asserted-by":"crossref","first-page":"e4251","DOI":"10.1093\/cid\/ciaa1727","article-title":"Comparative effectiveness of influenza vaccines among US Medicare beneficiaries ages 65 years and older during the 2019-2020 season","volume":"73","author":"Izurieta","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127361_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19020818","article-title":"Relative effectiveness of cell-cultured versus egg-based seasonal influenza vaccines in preventing influenza-related outcomes in subjects 18 years old or older: a systematic review and Meta-analysis","volume":"19","author":"Puig-Barbera","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127361_bb0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-021-00403-7","article-title":"Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance","volume":"6","author":"Arunachalam","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127361_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/v13101896","article-title":"Cell-adapted mutations and antigenic diversity of influenza B viruses in Missouri, 2019-2020 season","volume":"13","author":"Tang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127361_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41541-020-00227-x","article-title":"Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans","volume":"5","author":"Richards","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127361_bb0115","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/cid\/ciab566","article-title":"Comparison of the immunogenicity of cell culture-based and recombinant quadrivalent influenza vaccines to conventional egg-based quadrivalent influenza vaccines among healthcare personnel aged 18-64 years: a randomized open-label trial","volume":"73","author":"Dawood","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127361_bb0120","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1093\/cid\/ciac683","article-title":"Effect of repeat vaccination on immunogenicity of quadrivalent cell-culture and recombinant influenza vaccines among healthcare personnel aged 18-64 years: a randomized","volume":"76","author":"Gaglani","year":"2023","journal-title":"Open-Label Trial Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127361_bb0125","first-page":"ofad223","article-title":"Immunogenicity of high-dose egg-based, recombinant, and cell culture-based influenza vaccines compared with standard-dose egg-based influenza vaccine among health care personnel aged 18-65 years in 2019-2020. Open forum","volume":"10","author":"Naleway","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127361_bb0130","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa1608862","article-title":"Efficacy of recombinant influenza vaccine in adults 50 years of age or older","volume":"376","author":"Dunkle","year":"2017","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127361_bb0135","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.vaccine.2023.06.056","article-title":"Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design","volume":"41","author":"Zimmerman","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127361_bb0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza a virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127361_bb0145","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127361_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus, where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127361_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fimmu.2012.00087","article-title":"Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem","volume":"3","author":"Thomson","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127361_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/imcb.12312","article-title":"The protective potential of fc-mediated antibody functions against influenza virus and other viral pathogens","volume":"98","author":"Vanderven","year":"2020","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127361_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131531","article-title":"Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children","volume":"10","author":"Verschoor","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127361_bb0285","article-title":"Measuring influenza neutralizing antibody responses to a(H3N2) viruses in human sera by microneutralization assays using MDCK-SIAT1 cells","volume":"129","author":"Gross","year":"2017","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127361_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.1801208","article-title":"The multifaceted B cell response to influenza virus","volume":"202","author":"Lam","year":"2019","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127361_bb0185","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02372-23","article-title":"Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers","volume":"15","author":"Bean","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127361_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3128","article-title":"Molecular programming of B cell memory","volume":"12","author":"McHeyzer-Williams","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127361_bb0195","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nri.2016.94","article-title":"T follicular helper cells in space-time","volume":"16","author":"Qi","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127361_bb0200","doi-asserted-by":"crossref","first-page":"26494","DOI":"10.1038\/srep26494","article-title":"ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination","volume":"6","author":"Bentebibel","year":"2016","journal-title":"Sci Rep"},{"issue":"176","key":"10.1016\/j.vaccine.2025.127361_bb0205","doi-asserted-by":"crossref","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127361_bb0210","doi-asserted-by":"crossref","first-page":"1133781","DOI":"10.3389\/fimmu.2023.1133781","article-title":"Tracking of activated cTfh cells following sequential influenza vaccinations reveals transcriptional profile of clonotypes driving a vaccine-induced immune response","volume":"14","author":"Currenti","year":"2023","journal-title":"Front Immunol"},{"issue":"428","key":"10.1016\/j.vaccine.2025.127361_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8405","article-title":"Circulating T(FH) cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity","volume":"10","author":"Koutsakos","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127361_bb0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127361_bb0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127361_bb0245","unstructured":"WHO. Recommended composition of influenza virus vaccines for use in the 2018\u20132019 northern hemisphere influenza season. 2024 [cited 2024 November 4]; Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/lot-release\/seasonal-information-influenza-virus-vaccine."},{"key":"10.1016\/j.vaccine.2025.127361_bb0250","author":"Sanofi"},{"key":"10.1016\/j.vaccine.2025.127361_bb0255","author":"Sanofi"},{"key":"10.1016\/j.vaccine.2025.127361_bb0260","author":"FDA"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127361_bb0175","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.vaccine.2019.01.086","article-title":"Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production","volume":"37","author":"Herrera-Rodriguez","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127361_bb0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.vaccine.2008.09.092","article-title":"In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses","volume":"27","author":"Co","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127361_bb0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1699-0463.1999.tb01556.x","article-title":"The postvaccination antibody response to influenza virus proteins","volume":"107","author":"Cox","year":"1999","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127361_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127361_bb0280","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01150-19","article-title":"Monoclonal antibody responses after recombinant hemagglutinin vaccine versus subunit inactivated influenza virus vaccine: a comparative study","volume":"93","author":"Henry","year":"2019","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127361_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223662","article-title":"Antibody levels poorly reflect on the frequency of memory B cells generated following SARS-CoV-2, seasonal influenza, or EBV infection","volume":"11","author":"Wolf","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127361_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.465","article-title":"An in vitro microneutralization assay for influenza virus serology","volume":"2","author":"Cuevas","year":"2022","journal-title":"Curr Protoc"},{"key":"10.1016\/j.vaccine.2025.127361_bb0295","author":"WHO"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127361_bb0310","first-page":"707","article-title":"Overview of serological techniques for influenza vaccine evaluation: past","volume":"2","author":"Trombetta","year":"2014","journal-title":"Present and Future Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127361_bb0315","doi-asserted-by":"crossref","first-page":"RRN1152","DOI":"10.1371\/currents.RRN1152","article-title":"Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin","volume":"2","author":"Yang","year":"2010","journal-title":"PLoS Curr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127361_bb0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/viro.1997.8958","article-title":"Studies of the binding properties of influenza hemagglutinin receptor-site mutants","volume":"241","author":"Martin","year":"1998","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127361_bb0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza a viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.127361_bb0230","doi-asserted-by":"crossref","first-page":"26478","DOI":"10.1038\/srep26478","article-title":"HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation","volume":"6","author":"Wheatley","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127361_bb0235","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/JVI.03422-13","article-title":"Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages","volume":"88","author":"Whittle","year":"2014","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127361_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00375-18","article-title":"Structural and molecular characterization of the hemagglutinin from the fifth-epidemic-wave a(H7N9) influenza viruses","volume":"92","author":"Yang","year":"2018","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127361_bb0330","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127361_bb0335","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"10.1016\/j.vaccine.2025.127361_bb0340","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127361_bb0345","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmb.2004.02.020","article-title":"Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin","volume":"337","author":"Guthe","year":"2004","journal-title":"J Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127361_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"issue":"6044","key":"10.1016\/j.vaccine.2025.127361_bb0355","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza a viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"issue":"6100","key":"10.1016\/j.vaccine.2025.127361_bb0360","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"issue":"6044","key":"10.1016\/j.vaccine.2025.127361_bb0365","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza a hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"issue":"5993","key":"10.1016\/j.vaccine.2025.127361_bb0370","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.127361_bb0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-1759(00)00352-5","article-title":"Single epitope multiple staining to detect ultralow frequency B cells","volume":"249","author":"Townsend","year":"2001","journal-title":"J Immunol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:27:20Z","timestamp":1755898040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"alternative-id":["S0264410X25006589"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127361","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127361"}}